Search Results - "Babaev, Meir"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Psoriasis and Dementia: A Cross-sectional Study of 121,801 Patients by Kridin, K, Linder, D, Shalom, G, Piaserico, S, Babaev, M, Freud, T, Comaneshter, D, Cohen, A

    Published in Acta dermato-venereologica (19-08-2020)
    “…Data regarding the association between psoriasis and dementia are inconclusive. The aim of this study was to evaluate this association in the database of…”
    Get full text
    Journal Article
  2. 2

    Healthcare Service Utilization by 116,816 Patients with Atopic Dermatitis in Israel by Shalom, Guy, Babaev, Meir, Kridin, Khalaf, Schonmann, Yochai, Horev, Amir, Dreiher, Jacob, Shani, Michal, Tiosano, Shmuel, Fisher, Shani, Comaneshter, Doron, Cohen, Arnon D

    Published in Acta dermato-venereologica (01-04-2019)
    “…Understanding of the epidemiology and healthcare service utilization related to atopic dermatitis is necessary to inform the use of new treatments. This…”
    Get full text
    Journal Article
  3. 3

    Treatment of erosive oral lichen planus with local ultraviolet B phototherapy by Kassem, Riad, MD, Yarom, Noam, MD, Scope, Alon, MD, Babaev, Meir, MD, Trau, Henri, MD, Pavlotzky, Felix, MD

    “…Background Oral lichen planus (OLP) is a chronic inflammatory disease that can significantly affect the patient's quality of life. Objective We sought to…”
    Get full text
    Journal Article
  4. 4

    Psori Silk in Mild to Moderate Psoriasis: A Randomized Phase I-II Trial Study by Pavlotsky, Felix, Babaev, Meir, Barzilai, Aviv

    Published in Skinmed (2023)
    “…In patients with mild to moderate psoriasis, topical corticosteroids are usually the first-line of treatment; however, they are not suitable for long-term use…”
    Get more information
    Journal Article
  5. 5

    Demographic and health care service utilization by 4417 patients with hidradenitis suppurativa by Shalom, Guy, Babaev, Meir, Freud, Tamar, Tiosano, Shmuel, Pam, Nadav, Horev, Amir, Dreiher, Jacob, Vardy, Daniel A., Comaneshter, Doron, Cohen, Arnon D.

    “…Data on the health care utilization of patients with hidradenitis suppurativa (HS) in primary care settings are scarce. To investigate the health care service…”
    Get full text
    Journal Article
  6. 6

    Global perspectives for the management of onychomycosis by Gupta, Aditya K., Mays, Rachel R., Versteeg, Sarah G., Piraccini, Bianca Maria, Takwale, Anita, Shemer, Avner, Babaev, Meir, Grover, Chander, Di Chiacchio, Nilton G., Taborda, Paulo R. O., Taborda, Valeria B. A., Shear, Neil H., Piguet, Vincent, Tosti, Antonella

    Published in International journal of dermatology (01-10-2019)
    “…Onychomycosis is a fungal nail infection caused by dermatophytes, nondermatophyte molds, and yeasts. This difficult‐to‐treat chronic infection has a tendency…”
    Get full text
    Journal Article
  7. 7

    Psoriasis in Israel: demographic, epidemiology, and healthcare services utilization by Shalom, Guy, Zisman, Devy, Babaev, Meir, Horev, Amir, Tiosano, Shmuel, Schonmann, Yochai, Comaneshter, Doron, Cohen, Arnon D.

    Published in International journal of dermatology (01-09-2018)
    “…Background Updated data regarding the epidemiology of psoriasis and related healthcare utilization are lacking. Objective To investigate the epidemiology,…”
    Get full text
    Journal Article
  8. 8

    An Update on the Disappearing Nail Bed by Daniel, Ralph, Meir, Babaev, Avner, Shemer

    Published in Skin appendage disorders (01-03-2017)
    “…Background: The nail bed may epithelialize and develop dermatoglyphics after long-standing onycholysis. We have called this phenomenon the disappearing nail…”
    Get full text
    Journal Article
  9. 9

    Variability in Systemic Treatment Efficacy for Onychomycosis: Information That Clinical Studies Do Not Impart to the Office Dermatologist by Shemer, Avner, Daniel, Ralph, Rigopoulos, Dimitris, Farhi, Renata, Babaev, Meir

    Published in Skin appendage disorders (01-08-2018)
    “…Wide differences in the cure rates of onychomycosis in various clinical studies can be avoided if we bear in mind some insights that will help us make study…”
    Get full text
    Journal Article
  10. 10

    Continuous terbinafine and pulse itraconazole for the treatment of non-dermatophyte mold toenail onychomycosis by Shemer, Avner, Gupta, Aditya K., Kamshov, Shoni, Babaev, Meir, Hermush, Vered, Farhi, Renata, Daniel, C. Ralph, Foley, Kelly A.

    Published in The Journal of dermatological treatment (03-04-2021)
    “…Although dermatophytes are considered the predominant causative organisms in onychomycosis, non-dermatophyte mold (NDM) infections may be more prevalent than…”
    Get full text
    Journal Article
  11. 11

    Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure by Shemer, Avner, Gupta, Aditya K., Kamshov, Adaia, Babaev, Meir, Farhi, Renata, Daniel, C. Ralph, Foley, Kelly A.

    Published in Dermatologic therapy (01-09-2017)
    “…Recurrence rates are high for onychomycosis, with prophylactic topical antifungal use proposed to counter recurrence. Although this is a reasonable action for…”
    Get full text
    Journal Article
  12. 12

    A Retrospective Study Comparing K101 Nail Solution as a Monotherapy and in Combination with Oral Terbinafine or Itraconazole for the Treatment of Toenail Onychomycosis by Shemer, Avner, Gupta, Aditya K., Babaev, Meir, Barzilai, Aviv, Farhi, Renata, Daniel III, C. Ralph

    Published in Skin appendage disorders (01-08-2018)
    “…Background: Onychomycosis is a difficult-to-treat fungal infection of the nails. The efficacy of monotherapy is not ideal, and combination therapies provide an…”
    Get full text
    Journal Article
  13. 13